NEW YORK (GenomeWeb News) — Accelrys today said third-quarter revenues increased 1 percent as R&D spending fell 5 percent and loss increased 90 percent.
 
Separately today, Accelrys said it will partner with Pfizer to develop cheminformatic software.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $20.7 million from $20.4 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.